Blättern Human- und Zahnmedizin nach "Koziolek, Michael Prof. Dr." Betreuer
Anzeige 1-5 von 5
-
Evaluation zur Indikation einer Barorezeptor-Aktivierungstherapie an der Klinik für Nephrologie und Rheumatologie der Universitätsmedizin Göttingen. Eine retrospektive Studie der Jahre 2012 bis 2019.
(2023-04-11)Uncontrolled hypertension is a main risk factor for cardiovascular morbidity. Baroreflex activation therapy (BAT) is an effective therapy option addressing true resistant hypertension. We evaluated patients' eligibility ... -
Effekte der Barorezeptoraktivierungstherapie auf Marker des Endoplasmatischen Retikulum Stresses
(2019-11-04)Introduction: Arterial hypertension is present in 30-45% of the adult population and represents a significant public health problem. Although hypertension is one of the major risk factors for the high rate of cardiovascular ... -
Der CRP-Wert zum Zeitpunkt der Dialysekatheter-Implantation als Risikofaktor für die Entwicklung einer Katheter-assoziierten Komplikation
(2017-11-02)Abstract Background The prevalence of permanent hemodialysis catheters as hemodialysis access among patients with end-stage renal disease is increasing. Related complications, such as infection, have unfavorable effects ... -
Immunadsorption und Plasmapherese in der Behandlung von Multipler Sklerose und Neuromyelitis Optica
(2017-02-14)Background: Plasma exchange (PE) and immunoadsorption (IA) are alternative treatments of steroid-refractory relapses of multiple sclerosis (MS) or neuromyelitis optica (NMO). Methods: Adverse events and neurological ... -
Evaluation der Aktivierung von CD4+ T-Lymphozyten bei Patienten mit Sepsis und akutem Nierenversagen
(2014-12-19)A lower CD4+ ATP content even at the time of ICU admission is associated with a worse clinical outcome in patients suffering from sepsis. Moreover, regulatory T cells seem to attenuate nephrotoxic effects in cisplatin ...